We use cookies to understand how you use our site and to improve your experience. This includes personalizing content and advertising. To learn more, click here. By continuing to use our site, you accept our use of cookies. Cookie Policy.

Features Partner Sites Information LinkXpress hp
Sign In
Advertise with Us

Medtronic

Medtronic offers medical products and therapies for the treatment of cardiac and vascular diseases, diabetes, and neu... read more Featured Products: More products

Download Mobile App





Medtronic Displays Patient Monitoring Systems at MEDICA 2019

By HospiMedica International staff writers
Posted on 21 Nov 2019
Medtronic plc (Fridley, MN, USA) displayed its patient monitoring systems at the MEDICA 2019 International Trade Fair on November 18-21 in Düsseldorf, Germany. More...
MEDICA is the world's largest medical trade fair for medical technology, electromedical equipment, laboratory equipment, diagnostics and pharmaceuticals. More than 5,000 exhibitors from 70 countries presented their newest products and ideas at MEDICA 2019 which drew 120,000 trade visitors from over 170 countries.

Medtronic is among the world’s largest medical technology, services and solutions companies – alleviating pain, restoring health and extending life for millions of people around the world. At MEDICA 2019, Medtronic displayed its patient monitoring systems, including the Emprint SX ablation platform with Thermosphere technology, a cutting-edge, integrated surgical navigation and ablation platform that reduces procedural complexity and improves the targeting accuracy of soft tissue ablation. The Emprint SX’s navigation software improves successful antenna placement versus standard ultrasound guidance upon first attempt. Its advanced 3-D tracking shows the position of the Emprint SX ablation antenna and ultrasound transducer relative to the surgeon’s perspective in real-time.

Medtronic also displayed the Emprint ablation system with Thermosphere technology that can be used for ablation in other soft tissue within the body. The Thermosphere technology provides clinicians with three kinds of spatial energy control — thermal, field and wavelength. This maintains a predictable, spherical ablation zone throughout a procedure, and brings new confidence to the ablation of liver tumors.

Among other patient monitoring systems displayed by Medtronic at this year’s MEDICA was the Cardioblate 68000 generator which is easy to set up and use. Its advanced dose-response algorithm customizes energy delivery based on tissue impedance to achieve reliable, reproducible transmurality, ensuring transmural lesions that consistently result in conduction block. It features touch screen operation for adjusting ablation parameters, while audible tones and touch screen messages notify user of ablation status, transmurality, and other critical information.

Related Links:
Medtronic plc


Gold Member
Neonatal Heel Incision Device
Tenderfoot
Gold Member
NEW PRODUCT : SILICONE WASHING MACHINE TRAY COVER WITH VICOLAB SILICONE NET VICOLAB®
REGISTRED 682.9
Breast Imaging Monitor
Barco Coronis Onelook MDMC-32133 32MP
Gas Analyzer
GE SAM
Read the full article by registering today, it's FREE! It's Free!
Register now for FREE to HospiMedica.com and get access to news and events that shape the world of Hospital Medicine.
  • Free digital version edition of HospiMedica International sent by email on regular basis
  • Free print version of HospiMedica International magazine (available only outside USA and Canada).
  • Free and unlimited access to back issues of HospiMedica International in digital format
  • Free HospiMedica International Newsletter sent every week containing the latest news
  • Free breaking news sent via email
  • Free access to Events Calendar
  • Free access to LinkXpress new product services
  • REGISTRATION IS FREE AND EASY!
Click here to Register








Channels

Patient Care

view channel
Image Credit: Adobe Stock

AI Platform Personalizes Support Between Visits for Cancer Survivors

Cancer survivors often manage persistent side effects after treatment, including fatigue, anxiety, uncertainty, symptoms, stress, and questions between appointments. Clinical teams need ways to maintain... Read more

Point of Care

view channel
Image Credit: 123RF

Continuous Glucose Monitoring Identifies Cardiometabolic Risk in Adults Without Diabetes

Dysglycemia—abnormal blood glucose regulation—can fluctuate throughout the day and often escape conventional screening. Clinicians typically rely on fasting plasma glucose and hemoglobin A1c, which offer... Read more

Business

view channel
Image: The proposed acquisition would add NeoCast, an investigational next-generation liquid embolic technology for chronic subdural hematoma (cSDH), to Terumo Neuro’s neurovascular portfolio. (Photo courtesy of Arsenal Medical)

Terumo Neuro Acquisition Advances Liquid Embolic Technology for Chronic Subdural Hematoma

Terumo Neuro (Aliso Viejo, CA, USA) signed an agreement to acquire Arsenal Medical Inc. (Waltham, MA, USA), a privately held, clinical-stage biomaterials company. The proposed acquisition would add NeoCast,... Read more
Copyright © 2000-2026 Globetech Media. All rights reserved.